Activities of Atazanavir (BMS-232632) against a Large Panel of Human Immunodeficiency Virus Type 1 Clinical Isolates Resistant to One or More Approved Protease Inhibitors

To evaluate the cross-resistance profile of the human immunodeficiency virus type 1 protease inhibitor (PI) atazanavir (BMS-232632), a panel of 551 clinical isolates exhibiting a wide array of PI resistance profiles and a variety of genotypic patterns were assayed for susceptibility to atazanavir an...

पूर्ण विवरण

ग्रंथसूची विवरण

में प्रकाशित:	Antimicrob Agents Chemother
मुख्य लेखकों:	Colonno, Richard J., Thiry, Alexandra, Limoli, Kay, Parkin, Neil
स्वरूप:	Artigo
भाषा:	Inglês
प्रकाशित:	American Society for Microbiology (ASM) 2003
विषय:	Antiviral Agents
ऑनलाइन पहुंच:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC152527/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12654666/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.47.4.1324-1333.2003
टैग:	टैग जोड़ें कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!